Why Wall Street Is Dead Wrong About This Popular Stock Often, investors and Wall Street analysts focus on the short term and don't give enough thought to the long term.
These Artificial Intelligence (AI) Stocks Have Crushed Nvidia in 2026 With Gains of 67% and 121%. They Can Still Soar Higher Lumentum Holdings and Applied Materials are important players in the AI infrastructure space, which explains why their stock prices have been soaring this year.
Bloom Energy vs. Plug Power: Which Hydrogen Stock Is a Better Buy in 2026? Between Bloom Energy and Plug Power, one company is generating positive cash flows and growing its revenue at a torrid pace.
Why a Fund Made a $143 Million Bet on Indivior With Shares Up a Staggering 200% Indivior develops buprenorphine-based therapies for opioid dependence, serving healthcare providers and treatment centers worldwide.
Why This Fund Made a $30 Million Bet on Floor & Decor Amid a 30% Stock Drop Floor & Decor supplies hard surface flooring and installation products to professional installers and DIY customers across the U.S.
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More Vericel develops cell therapies for cartilage repair and burn care, serving hospitals and clinics across the United States.
1 AI Stock That Could Turn $500 per Month Into $1 Million Nebius could become one of the biggest long-term winners in the current disciplined phase of AI infrastructure spending.
Wix Stock Has Crashed This Past Year, and One Investor Exited a $4.35 Million Position Wix.com Ltd. delivers cloud-based website creation and business management tools to a global client base through a subscription model.
What to Know About a New $18 Million Bet on Cal-Maine Foods Cal-Maine Foods is a leading U.S. producer of shell eggs and specialty varieties for major grocery and foodservice customers nationwide.
Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge This clinical-stage biotech develops small molecule therapies for cancer and fibrotic diseases, focusing on galectin-3 and LOXL2 inhibitors.
What to Know About This Fund's $32.6 Million Porch Group Purchase This technology-driven firm delivers software and insurance solutions for home services professionals, homebuyers, and homeowners.
Can Sandisk Become a $1 Trillion Company in 5 Years? The memory specialist has a real shot at following Micron past that milestone.
Grindr Stock Is Down 49%. Here's Why One Investor Added $15.9 Million Grindr operates a digital platform serving the LGBTQ community through both subscription and advertising revenue streams.
What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year Ultragenyx develops therapies for rare genetic diseases, with a portfolio spanning approved biologics and a pipeline of gene therapies.
A Fund Sold $5.5 Million of This Regional Bank. Should Investors Follow? FB Financial Corporation provides commercial and consumer banking services across the southeastern U.S. through its FirstBank subsidiary.
2 Genius Stocks That Billionaire Bill Ackman Just Loaded Up On His hedge fund, Pershing Square Capital Management, bought large quantities of Amazon and Microsoft shares in the first quarter.
